Fay

formerly Fay Health

Fay is a life sciences company in New York, United States, founded in 2022. It has raised $80.0M across 4 rounds, most recently a $50.0M Series B in February 2025.

Your personal dietitian, covered by insurance

Headquarters
New York, New York
Employees
51–200
Founded
2022
Business Model
B2B2C
Total Funding
$80.0M
Last Round
$50.0M Series BFeb 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Fay is a three-sided AI marketplace redefining preventive care through personalized nutrition counseling. The platform connects patients with a network of 2,500+ registered dietitian nutritionists (RDs) covered by major insurance plans including United Healthcare, Aetna, Cigna, Anthem, and Blue Cross Blue Shield. Fay handles insurance billing end-to-end, enabling sessions that are often free or near-free for patients. The platform supports 30+ conditions including diabetes, PCOS, eating disorders, gut health, and weight management. Founded in 2022, Fay has grown to become one of the fastest-growing companies in health and wellness.

Summary

It lists 51–200 employees. It has raised $80.0M in total across 4 rounds, most recently a $50.0M Series B round in Feb 2025. Investors include General Catalyst, Forerunner Ventures and Goldman Sachs.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BFeb 2025
$50.0M

Sign up to see all 4 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021
Oscar HealthIPO

Oscar Health uses technology to deliver simple, personalized health insurance and member-care exp...

New York, United States1001–5000Healthcare, Insurance
ConvertibleTotal funding$1.8BOct 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Fay on Indexed.vc
<a href="https://indexed.vc/companies/fay"><img src="https://indexed.vc/api/badge/company/fay" alt="Fay on Indexed.vc" width="260" height="76" /></a>